Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Myriad Genetics, Beckman Coulter

Premium
Qiagen’s Artus CMV PCR Kit last week received the CE certification for diagnostic use in the European Union, and the company said that the kit is available immediately.
 
The Artus kits are intended for early quantitative detection of CMV, and are suitable for use with the ABI Prism 7000, 7700, and 7900HT SDS, LightCycler 1.1/1.2/1.5/2.0 Instruments, as well as Rotor-Gene 3000.
 

 
Myriad Genetics last week launched its BRACAnalysis Rearrangement Test for detecting rare, large rearrangements of DNA in the BRCA1 and BRCA2 genes. The test is intended to be performed on samples from women with exceptionally high risk, and who have tested negative for sequence mutations and the common large rearrangements already included in Myriad's test.
 

 
Beckman Coulter this week launched its Agencourt RNAdvance Tissue system for total RNA isolation from mammalian samplesusing paramagnetic bead nucleic acid purification technology. The system produces clean RNA with high recovery in a single tube or in 96-well formats, the company said.
 
The system can be automated on the Beckman Coulter Biomek NX liquid handling workstation, and it can produce RNA for microarray experiments when coupled with Agencourt RNACleantechnology.

Filed under

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.